Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma | BMC Cancer | Full Text

Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma | BMC Cancer | Full Text

Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma

Oral squamous cell carcinoma (OSCC) is an aggressive human malignancy. Because of late diagnosis and recurrence of OSCC, the treatment of patients with OSCC is often ineffective. Thus, finding novel biomarkers...

Authors:Ratakorn Srisuttee, Areeya Arayataweegool, Patnarin Mahattanasakul, Napadon Tangjaturonrasme, Virachai Kerekhanjanarong, Somboon Keelawat, Apiwat Mutirangura and Nakarin Kitkumthorn

Citation:BMC Cancer 2020 20:218

Content type:Research article

Published on: 14 March 2020

• ViewFull Text
 
• ViewPDF